Thank you for correcting the text in this article. Your corrections improve Papers Past searches for everyone. See the latest corrections.

This article contains searchable text which was automatically generated and may contain errors. Join the community and correct any errors you spot to help us improve Papers Past.

Article image
Article image
Article image
Article image
Article image
Article image

POLICE BAN ON NEW DRUG

DEATHS REPORTED IN FRANCE

(Rec. 8 p.m.) PARIS, July 6. Police combed chemists’ shops throughout France tonight for bottles of a new “wonder drug,” Stalinon, which is believed to be responsible for 14 deaths. The drug—intended as a treatment for boils and abscesses —is considered by police doctors to be causing encephalitis (inflammation of the brain). The latest victims attributed to the drug are a man and a woman in Cambrai, eastern France, who died from encephalitis after the drug had been prescribed for them. A similar case was reported from| La Bachellerie in Central France, last night, and a small boy admitted to a Paris hospital after receiving Stalinon treatment was reported today to be seriously ill. „ . The Ministry of Health banned further sales of the drug yesterday, and chemists are asked to hand over ■ the 2400 bottles distributed since the • drug was first put on the market a . few months ago. > Health authorities approved the drug - last January, but mice treated with it » in a Paris laboratory yesterday died immediately.

Permanent link to this item
Hononga pūmau ki tēnei tūemi

https://paperspast.natlib.govt.nz/newspapers/CHP19540708.2.104

Bibliographic details
Ngā taipitopito pukapuka

Press, Volume XC, Issue 27396, 8 July 1954, Page 11

Word count
Tapeke kupu
177

POLICE BAN ON NEW DRUG Press, Volume XC, Issue 27396, 8 July 1954, Page 11

POLICE BAN ON NEW DRUG Press, Volume XC, Issue 27396, 8 July 1954, Page 11

Help

Log in or create a Papers Past website account

Use your Papers Past website account to correct newspaper text.

By creating and using this account you agree to our terms of use.

Log in with RealMe®

If you’ve used a RealMe login somewhere else, you can use it here too. If you don’t already have a username and password, just click Log in and you can choose to create one.


Log in again to continue your work

Your session has expired.

Log in again with RealMe®


Alert